PRESS RELEASE published on 01/17/2025 at 15:25, 10 months 19 days ago Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program Bausch Health and Salix Pharmaceuticals announce XIFAXAN selected for drug price negotiation program with CMS for 2027. Details on XIFAXAN and safety information included Salix Pharmaceuticals XIFAXAN Bausch Health CMS Drug Price Negotiation
BRIEF published on 12/12/2024 at 13:05, 11 months 24 days ago Bausch Health Considers Potential Sale of Bausch + Lomb Bausch Health Strategic Plans Stock Volatility Sale Rumors Bausch + Lomb
BRIEF published on 12/12/2024 at 13:05, 11 months 24 days ago Bausch Health envisage une éventuelle vente de Bausch + Lomb Bausch Santé Plans Stratégiques Bausch + Lomb Rumeurs De Vente Volatilité Des Actions
PRESS RELEASE published on 12/12/2024 at 13:00, 11 months 24 days ago Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb Bausch Health considers potential sale of subsidiary Bausch + Lomb to complete full separation. Response to CIRO's request regarding market rumors and stock volatility Bausch Health CIRO Market Rumors Stock Volatility Subidiary Sale
BRIEF published on 12/05/2024 at 14:05, 1 year ago Second Annual Opioid-Induced Constipation Awareness Day Recognized Salix Pharmaceuticals Bausch Health Chronic Pain Opioid-Induced Constipation Awareness Day
BRIEF published on 12/05/2024 at 14:05, 1 year ago La deuxième Journée annuelle de sensibilisation à la constipation induite par les opioïdes est reconnue Douleur Chronique Bausch Santé Produits Pharmaceutiques Salix Constipation Induite Par Les Opioïdes Journée De Sensibilisation
PRESS RELEASE published on 12/05/2024 at 14:00, 1 year ago Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day Bausch Health Companies Inc., Salix Pharmaceuticals, and healthcare organizations join forces for the second annual Opioid-Induced Constipation Awareness Day to raise awareness and support patients affected by OIC Bausch Health Companies Inc. Healthcare Organizations Awareness Opioid-Induced Constipation Awareness Day OIC
BRIEF published on 12/02/2024 at 14:05, 1 year ago Bausch Health Appoints New Chief Medical Officer and Head of R&D Innovation Pharmaceuticals R&D Bausch Health Jonathan Sadeh
BRIEF published on 12/02/2024 at 14:05, 1 year ago Bausch Health nomme un nouveau directeur médical et un nouveau directeur de la recherche et du développement Innovation Recherche Et Développement Bausch Santé Médicaments Jonathan Sadeh
PRESS RELEASE published on 12/02/2024 at 14:00, 1 year ago Bausch Health Appoints New Chief Medical Officer and Head of R&D Bausch Health Companies Inc. appoints Jonathan Sadeh M.D., M.Sc as Executive VP, Chief Medical Officer & Head of R&D, emphasizing commitment to innovation & excellence Innovation Bausch Health Companies Inc. R&D Chief Medical Officer Jonathan Sadeh
Published on 12/06/2025 at 00:25, 29 minutes ago GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 54 minutes ago Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 1 hour 24 minutes ago 55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 21:45, 3 hours 9 minutes ago When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 22:15, 2 hours 38 minutes ago CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 2 hours 42 minutes ago EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 5 hours 56 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 6 hours 38 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 23:00, 1 hour 54 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 54 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 54 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 1 hour 54 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 7 hours 36 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible